Benzinga | May 6, 2021 05:37PM EDT

Mirati Therapeutics Q1 EPS $(2.67) Down From $(2.02) YoY

Mirati Therapeutics (NASDAQ:MRTX) reported quarterly losses of $(2.67) per share. This is a 32.18 percent decrease over losses of $(2.02) per share from the same period last year.